Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

from A Health Podyssey · host Health Affairs

In this episode, Rob Lott interviews Jennifer Kao of the UCLA Anderson School of Management in front of a live audience about her paper in the October 2025 issue of Health Affairs exploring the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products.Order the October 2025 issue of Health Affairs.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcast for everyone.

Episode metadata supplied by the publisher feed · Published Oct 28, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Inside U.S. Generic Drug Approvals: Risk, Regulation & Policy w/ Jennifer Kao

0:00 31:26

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of A Health Podyssey?

This episode is 31 minutes long.

When was this A Health Podyssey episode published?

This episode was published on October 28, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this A Health Podyssey episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!